Regulation News
Financial regulation news from the SEC, FINRA, and government agencies. Track policy changes, enforcement actions, and compliance updates affecting markets.
GSK's RSV Vaccine Advances in China Review, Analysts Adjust Targets
GSK's respiratory syncytial virus vaccine Arexvy has entered regulatory review in China, a key market for adult immunization. The stock declined Monday despite several brokerages raising price targets.
Telstra Shares Dip Amid Spectrum Fee Dispute Ahead of Earnings
Telstra shares edged lower as the telecom giant pushes for a cap on spectrum renewal costs, challenging regulator proposals ahead of its half-year results.
Hims & Hers Shares Plunge 16% After Halting $49 Weight-Loss Pill Amid Novo Nordisk Lawsuit
Hims & Hers Health stock tumbled in after-hours trading following the withdrawal of its compounded semaglutide product and a patent infringement lawsuit from Novo Nordisk. Leerink Partners reduced its price target on the company.
Meta Shares Gain as EU Considers Forcing WhatsApp to Open AI Access
Meta Platforms stock advanced 2.4% in after-hours trading following reports that European Union regulators are weighing interim measures to compel WhatsApp to allow competing AI assistants on its platform.
Nexstar Shares Surge on Political Support for Tegna Acquisition Amid FCC Rule Review
Nexstar Media Group stock jumped 14.3% after former President Trump and FCC Chairman Carr endorsed its Tegna takeover. A Senate hearing on broadcast ownership rules is set for February 10.
Netflix Shares Drop as DOJ Scrutinizes Warner Bros Acquisition
Netflix stock declined over 2% after the Department of Justice issued a civil subpoena related to its proposed Warner Bros deal, raising regulatory uncertainty.
EU Threatens Interim Action Against Meta Over WhatsApp AI Restrictions
Meta shares gained 0.6% despite EU antitrust warnings targeting its limits on rival AI assistants within WhatsApp. The European Commission may impose rare interim measures to preserve competition.
NIO Shares Dip on Major Vehicle Recall Over Software Glitch
NIO shares fell in premarket trading after Chinese regulators ordered a recall of over 246,000 vehicles due to a software issue that can cause in-car screens to black out temporarily.
SSE Shares Approach 52-Week High Amid Regulatory Scrutiny and Investment Focus
SSE shares gained 0.32% to 2,518p in early London trading, nearing a 52-week peak. Investors are monitoring regulatory decisions and the company's £1.8 billion network investment plan.
GSK Nears 52-Week Peak on COPD Drug Approval and U.S. Pricing Developments
GSK shares advanced 0.6% in London trading, approaching a 52-week high following EU approval for Nucala in COPD and amid U.S. drug discount initiatives. Insider trading activity and the upcoming ex-dividend date remain in focus.
South Korean Regulators Eye Stricter Crypto Oversight After Bithumb's $40 Billion Error
South Korea's financial watchdog is pushing for tighter cryptocurrency regulations following a major incident at exchange Bithumb, which mistakenly distributed over $40 billion in Bitcoin to users. Authorities are considering enhanced inspections and addressing systemic vulnerabilities.
Gilead Hits 52-Week Peak on FDA Label Expansion for Yescarta, Earnings in Focus
Gilead Sciences reached a 52-week high after the FDA approved a label update for its Yescarta therapy, expanding use to a rare brain lymphoma. The stock's rally comes ahead of the company's quarterly earnings report.